Literature DB >> 1926186

A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin.

P Bette1, A Oksche, F Mauler, C von Eichel-Streiber, M R Popoff, E Habermann.   

Abstract

The three clostridial cytotoxins, i.e. alpha-toxin of C. novyi (Tox alpha-nov), toxin B of C. difficile (ToxB-dif) and lethal toxin of C. sordellii (LT-sor) consist of single peptide chains of about 200,000 (Tox alpha-nov), 250,000 (LT-sor) and 275,000 (ToxB-dif) mol. wts. ToxB-dif and LT-sor but not Tox alpha-nov cross-reacted with rabbit polyclonal antibodies. Toxicity upon i.v. injection in mice was similar (LD50, 100 hr, 50-200 ng/kg) and was characterized by a slowly developing fluid loss into the interstitial space. When injected into the rat paw the toxins caused a delayed local edema lasting for days. In vitro the three toxins provoked a persistent retraction of endothelial cells cultured from pig pulmonary artery. ToxB-dif and Tox alpha-nov triggered the accumulation of F-actin in the perinuclear region at the expense of the tight peripheral bands whereas LT-sor led to a random loss of microfilament structure. The toxins inhibited uridine incorporation into endothelial or chicken embryonic cells whereas T 84 cells responded by an about 10-fold increase of uridine incorporation. Neither toxin ADP-ribosylated actin. The similarities between the three cytotoxins warrant their arrangement into a common group which perturbs the microfilament system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926186     DOI: 10.1016/0041-0101(91)90224-f

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  17 in total

1.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Effects of cytotoxic necrotizing factor 1 and lethal toxin on actin cytoskeleton and VE-cadherin localization in human endothelial cell monolayers.

Authors:  V Vouret-Craviari; D Grall; G Flatau; J Pouysségur; P Boquet; E Van Obberghen-Schilling
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability.

Authors:  Blandine Geny; Huot Khun; Catherine Fitting; Leticia Zarantonelli; Christelle Mazuet; Nadège Cayet; Marek Szatanik; Marie-Christine Prevost; Jean-Marc Cavaillon; Michel Huerre; Michel R Popoff
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

4.  Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition.

Authors:  F Hofmann; C Busch; K Aktories
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Purification and characterization of alpha-toxin produced by Clostridium novyi type A.

Authors:  D W Ball; R L Van Tassell; M D Roberts; P E Hahn; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.

Authors:  F Hofmann; A Herrmann; E Habermann; C von Eichel-Streiber
Journal:  Mol Gen Genet       Date:  1995-06-25

8.  Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A.

Authors:  Tim Du; Michelle J Alfa
Journal:  Can J Infect Dis       Date:  2004-03

Review 9.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.

Authors:  D Sanders; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.